Holger Borchers

Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?— results of a study in 50 patients

U. Cremerius, Joachim E. Wildberger, Holger Borchers et al. · Urology · 1999 · 124 citations

Medicine, Nuclear Medicine, Oncology +17

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors

Frederick J. Meyers, Paul H. Gumerlock, Sung Gil et al. · Cancer · 1998 · 99 citations

Medicine, Oncology, Pathology +17

Is Prostate-Specific Antigen a Reliable Marker of Bone Metastasis in Patients with Newly Diagnosed Cancer of the Prostate?

J.M. Wolff, Michael Zimny, Holger Borchers et al. · European Urology · 1998 · 69 citations

Medicine, Oncology, Urology +16

Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer

Michael Pinkawa, Marc D. Piroth, Richard Holý et al. · Radiotherapy and Oncology · 2010 · 48 citations

Medicine, Oncology, Radiation Oncology +16

Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment

Michael Pinkawa, Karin Fischedick, Bernd Gagel et al. · BMC Cancer · 2009 · 43 citations · Full text

Medicine, Oncology, Urology +13